Vertex Planning Partners LLC bought a new stake in CME Group Inc. (NASDAQ:CME – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 6,878 shares of the financial services provider’s stock, valued at approximately $1,597,000.
A number of other institutional investors have also made changes to their positions in the business. Vanguard Group Inc. boosted its position in CME Group by 1.0% in the 4th quarter. Vanguard Group Inc. now owns 34,243,090 shares of the financial services provider’s stock valued at $7,952,273,000 after buying an additional 326,623 shares during the last quarter. Geode Capital Management LLC boosted its holdings in CME Group by 1.8% in the third quarter. Geode Capital Management LLC now owns 8,284,745 shares of the financial services provider’s stock valued at $1,823,964,000 after acquiring an additional 142,692 shares during the last quarter. Norges Bank acquired a new stake in CME Group in the fourth quarter worth about $1,107,389,000. Raymond James Financial Inc. bought a new stake in CME Group during the 4th quarter worth about $871,063,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in CME Group by 3.3% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 3,054,380 shares of the financial services provider’s stock valued at $710,143,000 after purchasing an additional 96,301 shares during the period. 87.75% of the stock is owned by institutional investors.
CME Group Trading Down 0.3 %
Shares of NASDAQ:CME opened at $261.85 on Friday. The firm has a market cap of $94.36 billion, a price-to-earnings ratio of 27.08, a PEG ratio of 6.76 and a beta of 0.53. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $267.91. The company’s fifty day simple moving average is $249.06 and its 200 day simple moving average is $235.32. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10.
CME Group Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th were given a dividend of $1.25 per share. The ex-dividend date of this dividend was Friday, March 7th. This represents a $5.00 dividend on an annualized basis and a yield of 1.91%. This is an increase from CME Group’s previous quarterly dividend of $1.15. CME Group’s dividend payout ratio is 51.71%.
CME Group declared that its Board of Directors has authorized a share repurchase program on Thursday, December 5th that allows the company to buyback $3.00 billion in outstanding shares. This buyback authorization allows the financial services provider to reacquire up to 3.4% of its shares through open market purchases. Shares buyback programs are usually an indication that the company’s leadership believes its shares are undervalued.
Analyst Ratings Changes
Several equities research analysts have recently commented on CME shares. Oppenheimer lifted their price target on shares of CME Group from $258.00 to $269.00 and gave the stock an “outperform” rating in a research report on Thursday, February 13th. Keefe, Bruyette & Woods lifted their target price on shares of CME Group from $256.00 to $257.00 and gave the stock a “market perform” rating in a report on Friday, February 14th. Raymond James upgraded CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 price target on the stock in a research report on Monday, March 10th. JPMorgan Chase & Co. upped their price objective on CME Group from $209.00 to $212.00 and gave the company an “underweight” rating in a report on Thursday, February 13th. Finally, Barclays raised their target price on CME Group from $257.00 to $263.00 and gave the stock an “equal weight” rating in a report on Thursday, February 13th. Four investment analysts have rated the stock with a sell rating, eight have given a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $238.93.
View Our Latest Research Report on CME
Insider Transactions at CME Group
In other news, insider Julie Winkler sold 11,592 shares of the stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the completion of the transaction, the insider now directly owns 21,885 shares in the company, valued at $5,453,085.45. This represents a 34.63 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, COO Suzanne Sprague sold 1,500 shares of CME Group stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $256.83, for a total value of $385,245.00. Following the completion of the sale, the chief operating officer now directly owns 8,036 shares in the company, valued at approximately $2,063,885.88. This represents a 15.73 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 27,076 shares of company stock valued at $6,871,496 in the last ninety days. 0.30% of the stock is currently owned by corporate insiders.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More
- Five stocks we like better than CME Group
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to SellĀ
- What is a Bond Market Holiday? How to Invest and Trade
- Top 3 Beverage Stocks Pouring Out Profits
- How to Invest in Small Cap StocksĀ
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.